FDA Official Was ‘Lutterly’ Lacking
3 CommentsBy Ed Silverman // June 13th, 2007 // 11:26 am
That’s the pithy headline Merrill Goozner came up with to describe the appearance yesterday by Randall Lutter, the FDA’s deputy commish, before a House subcommittee that was holding a PDUFA hearing. Randy, it seems, was “woefully unprepared” to address a few of the day’s pressing issues, according to Goozner, who heads the Integrity in Science project for the Center for Science in the Public Interest. For instance, he writes this….
“The most entertaining back-and-forth involved Rep. Diane DeGette (D-CO), who at a previous subcommittee meeting had asked the FDA for some data involving medical devices. They were supposed to have responded in writing within a few weeks of the hearing – a typical response at Congressional hearings when the witness can’t immediately put his hands on the information being requested. A month ago, DeGette wrote a follow-up letter asking “where’s the data?” When she brought that letter to Lutter’s attention today, he admitted that he hadn’t read it because he hadn’t seen it.”
“Rep. Jan Schakowsky (D-Ill.) asked Lutter about the recent case involving the scientist who tried to issue a warning about Avandia a year ago, but was told by her higher-ups at the agency to sit down and shut up. Schakowsky also mentioned the case of David Ross, who recently departed for the Veterans Administration after blowing the whistle on Ketek, an antibiotic with dangerous side effects.
“We take these concerns very seriously,†Lutter said. “I am unfamiliar with their cases.â€
Hard to believe. Randy, a former fellow at the American Enterprise Institute, may not know every detail, but he’s the deputy commish. He ought to know enough to provide a proper response to the public. He needs to get up to speed. And he also needs to pay more attention to his mail.
You can read more here.
Laurie
The bigger question is Where was Andrew C. von Eschenbach??
John Mack
“Eschew von Eschenbach” decided to “avoid” the spotlight.
Laurie
Pretty telling when the head of the FDA doesn’t even bother to show for the most important hearing that the FDA has. Hmmmm is von Eschenback on his way out???